论文部分内容阅读
我院于2008年8月至2013年8月,采用多西他赛联合表阿霉素(TE方案)化疗方案治疗局部晚期或转移性乳腺癌患者68例,疗效显著,耐受性良好,可作为此类患者的治疗选择。报告如下。1资料与方法1.1临床资料病例选择标准:经病理或者细胞学证实为晚期或转移性乳腺癌者,KPS评分≥70分;肝肾功基本正常,心电图基本正常;并有临床可测量或可评价的目标病灶或转移灶:体检测量病灶直径≥
In our hospital from August 2008 to August 2013, docetaxel combined with epirubicin (TE regimen) chemotherapy in the treatment of 68 cases of locally advanced or metastatic breast cancer patients, the effect was significant, well tolerated, and As a treatment option for such patients. The report is as follows. 1 Materials and Methods 1.1 Clinical data Case selection criteria: pathologically or cytologically confirmed as advanced or metastatic breast cancer, KPS score ≥ 70 points; liver and kidney function was normal, basically normal ECG; and clinically measurable or evaluable Of the target lesion or metastasis: physical examination lesion diameter ≥